Rockefeller Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Rockefeller Capital Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81M	Buy	15,245 +14,012	+1,136%	+$1.52M	﹤0.01%	1436
2026 Q1	$128K	Buy	1,233 +3	+0.2%	+$317	﹤0.01%	2732
2025 Q4	$129K	Buy	1,230 +209	+20%	+$21K	﹤0.01%	2589
2025 Q3	$94.5K	Buy	+1,021	New	+$89.4K	﹤0.01%	2603
2023 Q1	–	Sell	-898	Closed	-$70K	–	3368
2022 Q4	$70K	Buy	898 +100	+13%	+$7.69K	﹤0.01%	2220
2022 Q3	$56K	Hold	798	–	–	﹤0.01%	2287
2022 Q2	$59K	Buy	798 +250	+46%	+$19K	﹤0.01%	2208
2022 Q1	$43K	Buy	+548	New	+$42.5K	﹤0.01%	2370

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Rockefeller Capital Management's PJP Position: Q2 2026 in Review

Rockefeller Capital Management increased its Invesco Pharmaceuticals ETF (PJP) stake by 1,136% in Q2 2026, buying an estimated $1.52M and bringing the position to 15,245 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

Rockefeller Capital Management first reported a position in PJP in Q1 2022 and has held it in 8 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Rockefeller Capital Management held 15,245 shares of Invesco Pharmaceuticals ETF worth $1.81M as of Q2 2026.
Rockefeller Capital Management bought 14,012 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $1.52M.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1436 holding.
Rockefeller Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2022 and has held it in 8 quarters since.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.